Drug profile · INN
oxygen
OXYGEN, USP
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
oxygen (OXYGEN, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12311029
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein
granted -
US 12303618
Oxygen-generating cryogels
granted -
US 12233103
Indoleamine 2,3-dioxygenase based immunotherapy
granted -
US 12005194
Configurable oxygen concentrator and related method
granted -
US 11884707
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
granted -
US 11878053
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
granted -
US 11839659
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein
granted -
US 11648302
Indoleamine 2,3-dioxygenase based immunotherapy
granted
Frequently asked questions
What is oxygen?
oxygen (OXYGEN, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for oxygen?
OXYGEN, USP is a marketed brand name for oxygen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxygen?
oxygen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.